Advocate on issues related to transboundary animal disease monitoring, control, and prevention, including as it relates to avian influenza in animal agriculture. Educate Members of Congress and the Administration on Boehringer's capabilities to address emerging animal diseases.
2025 · 2nd Quarter (Apr 1 - June 30)
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Filed by INVARIANT LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 17, 2025
- Income
- $70,000.00
- Expenses
- Not reported
- Registrant
- INVARIANT LLC
- Filing UUID
- b94b908d-4692-4937-9dbd-adcf7bad7ef7
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.